Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 51INDUSTRY 31UNKNOWN 1OTHER_GOV 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 40Lymphoma 37Lymphoma, Follicular 33Leukemia, Lymphocytic, Chronic, B-Cell 32Lymphoma, Mantle-Cell 23Lymphoma, Non-Hodgkin 22Lymphoma, B-Cell, Marginal Zone 19Burkitt Lymphoma 19Waldenstrom Macroglobulinemia 14Leukemia 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, Large-Cell, Immunoblastic 10Multiple Myeloma 6Lymphoma, B-Cell 6Leukemia, Hairy Cell 6Hodgkin Disease 6Leukemia, Prolymphocytic 5Myelodysplastic Syndromes 4Lymphoma, AIDS-Related 4Dendritic Cell Sarcoma, Interdigitating 4Plasmablastic Lymphoma 3Lymphoma, Primary Effusion 3Lymphoma, Large-Cell, Anaplastic 3HIV Infections 3Epstein-Barr Virus Infections 3Neoplasms, Plasma Cell 2Neoplasms 2Neoplasm, Residual 2Myeloproliferative Disorders 2Lymphoproliferative Disorders 2

Interventions

Peripheral Blood Stem Cell Transplantation 5fludarabine phosphate 4Radiotherapy 4Antilymphocyte Serum 4Vincristine 3Vinblastine 3Procarbazine 3Prednisolone 3Methylprednisolone 3Melphalan 3Filgrastim 3Doxorubicin 3Cyclophosphamide 3Chlorambucil 3Busulfan 3Bortezomib 3Bevacizumab 3tipifarnib 2Vorinostat 2Sorafenib 2Oxaliplatin 2Mycophenolic Acid 2Methotrexate 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Dacarbazine 2Cyclosporine 2Bleomycin 2Biopsy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Recurrence × Rituximab × Clear all
NCT00036855 2013-01-17

Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma

National Cancer Institute (NCI)

Phase 1 Terminated
36 enrolled
LymphoidSarcoma

Burkitt Lymphoma, Recurrence, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡